Research progress on mitochondrial mechanism of myocardial protection in ischemic preconditioning

向岑,魏义勇,王海英
DOI: https://doi.org/10.3760/cma.j.cn321761-20191216-00102
2020-01-01
Abstract:Recently, mitochondria are the main organelles used to study ischemic preconditioning (IPC) against myocardial ischmia/reperfusion injury (MI/RI). Mitochondrial proteins such as connexins 43 (Cx43), cyclophilin D (CyPD) are involved in regulating the biological functions of mitochondria and affecting the energy metabolism of cardiomyocytes via regulating the opening and closing of mitochondrial mem-brane ATP-sensitive potassium channels (mitoK ATP), mitochondrial permeability transition pore (mPTP) and mitochondrial sodium-calcium exchange protein are involved in regulating the biological functions of mitochondria and affecting the energy metabolism of cardiomyocytes. In addition, IPC activates the phosphatidylinositol3-kinase-Akt-rapamycin target protein signaling pathway, then inhibits excessive autophagy, and exerts IPC myocardial protection.IPC regulates the expression of mitochondrial related genes such as miRNA and mitochondrial DNA, affects the structural integrity of mitochondria and ATP synthesis, and reduces MI/RI. The mechanism of IPC myocardial protection is closely related to mitochondria. Therefore, further study of the mitochondrial mechanism of IPC myocardial protection is beneficial to discover new targets for mitigating MIRI and provide scientific basis for clinical practice.
What problem does this paper attempt to address?